Other
Heart Transplantation
0
Pipeline Programs↗
4
Active Trials↗
0
Companies Involved↗
Heart Transplantation is an early-stage landscape with 0 programs across 0 companies.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
18
clinical trials
Completed6 · 33%
Recruiting4 · 22%
Unknown status3 · 17%
Withdrawn3 · 17%
Terminated2 · 11%
Clinical Trials
Trial Activity
18 trials
Belatacept in Heart Transplantation
Recruiting·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT06478017·66 enrolled
Daratumumab-SC for Highly Sensitized Patients Awaiting Heart Transplantation
Completed·—·Phase 1·NCT04610320·8 enrolled
Safety and Efficacy of Desensitization Therapy in Sensitized Participants Awaiting Heart Transplantation
Terminated·National Institute of Allergy and Infectious Diseases (NIAID)·Phase 2·NCT01769443·2 enrolled
Study of Daratumumab for Decreasing Circulating Antibodies in Sensitized Patients Awaiting Heart Transplantation
Withdrawn·—·Phase 1·NCT04088903
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)